Holen Sie sich die Stockscreener-App
44.39
2.35%
-1.07
Handel nachbörslich:
46.90
2.51
+5.65%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Decoding Hims & Hers Health Inc (HIMS): A Strategic SWOT Insight - GuruFocus
Hims & Hers Health Inc (HIMS) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance
Hims & Hers Health Reports Strong Q3 2025 Growth - TipRanks
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Key facts: Novo Nordisk Q3 revenue up 9.4%; bids $8.5B for Metsera; Hims launches semaglutide - TradingView
Hims Hers (HIMS) Q3 2025 Earnings Call Transcript - The Globe and Mail
Hims and Hers tops revenue estimates as telehealth provider attracts more users - Reuters
Earnings call transcript: Hims & Hers Health Q3 2025 misses EPS, stock rebounds - Investing.com Philippines
Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S. - MarketWatch
Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks - FinancialContent
Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates - Yahoo! Finance Canada
Hims & Hers Health in discussions with Novo Nordisk to sell Wegovy - Seeking Alpha
Hims & Hers Health Third-Quarter Revenue Jumps as Subscribers Grow - The Wall Street Journal
Hims & Hers Health rises after narrowing 2025 EBITDA guidance, Q3 EPS miss - Seeking Alpha
After-hours movers: Palantir, Hims & Hers Health, Sarepta Therapeutics, Sanmina - Investing.com Canada
Hims & Hers Health (NYSE:HIMS) Issues Quarterly Earnings Results, Meets Expectations - MarketBeat
Hims & Hers Health Q3 revenue tops estimates as subscriber growth jumps - Investing.com Australia
Hims Shares Rise on Talks to Offer Novo’s New Obesity Pill - Bloomberg.com
Hims & Hers Health Q3 revenue tops estimates as subscriber growth jumps By Investing.com - Investing.com South Africa
Earnings live: Palantir stock rises modestly on strong results, Hims & Hers stock surges - Yahoo Finance
Hims and Hers beats revenue estimates on strong subscriber growth - Yahoo Finance
Hims & Hers Q3 2025 Earnings: Revenue Beats Forecasts on Subscriber GrowthNews and Statistics - IndexBox
Hims & Hers Stock Pops After Q3 Earnings: Here's Why - Benzinga
Hims and Hers up after beating quarterly revenue estimates - TradingView
Hims & Hers Health’s (NYSE:HIMS) Q3 Sales Top Estimates - Yahoo Finance
Stock Market Today: Palantir, Vertex, and Hims & Hers Report After the Closing Bell - TheStreet
Hims and Hers misses quarterly profit estimates - Yahoo! Finance Canada
Hims rises on revenue beat, discloses it’s again in partnership talks with Novo - Sherwood News
How we’re reaching more customers with a new standard of care - Hims & Hers Newsroom
Hims and Hers Beats Revenue Estimates on Strong Subscriber Growth - US News Money
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results - The Joplin Globe
Notable Monday Option Activity: PFGC, GRPN, HIMS - Nasdaq
Hims & Hers Health Stock Jumps After-Hours As Q3 Growth, Novo Nordisk Talks Fuel Bullish Retail Bets - Stocktwits
Hims & Hers Q3 Preview: GLP-1 Drug Expansion Draws Investor Focus - Stocktwits
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? - Yahoo Finance
PREVIEW: Hims & Hers dips; focus on weigth-loss drug - TradingView
Hers Health, Inc. Reports Third Quarter 2025 Financial Results - Hims Investor Relations
Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED) - Benzinga
Hims & Hers Stock Seeks Support as Earnings Casts a Shadow - AskTraders.com
Intellectus Partners LLC Buys Shares of 61,036 Hims & Hers Health, Inc. $HIMS - MarketBeat
7,345 Shares in Hims & Hers Health, Inc. $HIMS Purchased by W.G. Shaheen & Associates DBA Whitney & Co - MarketBeat
Hims & Hers Health, Inc. $HIMS Position Lifted by X Square Capital LLC - MarketBeat
Stock Market Today: S&P 500, Dow Jones Futures Rise After Stellar October Gains— Micron Tech, Palantir, Hims & Hers In FocusSPDR S&P 500 (ARCA:SPY) - Benzinga
Promising Healthcare Stocks Worth WatchingOctober 31st - MarketBeat
Hims & Hers Health (HIMS): Exploring Valuation as Q3 Earnings and GLP-1 Launch Boost Market Activity - Yahoo Finance
Hims & Hers Health (HIMS) Q3 Earnings Preview: Revenue Growth An - GuruFocus
Promising Healthcare Stocks To Watch NowNovember 2nd - MarketBeat
State of Michigan Retirement System Grows Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Retirement Systems of Alabama Purchases 6,930 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
New York Life Investment Management LLC Takes $963,000 Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health (HIMS) Q3 Earnings: What To Expect - Barchart.com
Top Healthcare Stocks To ConsiderNovember 1st - MarketBeat
Yong Rong HK Asset Management Ltd Sells 1,450,200 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Nisa Investment Advisors LLC Acquires 14,106 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
HIMS Shows Positive Momentum with Increased Options Activity - GuruFocus
Hims & Hers Stock Up on JPMorgan Stake, GLP-1 ExpansionNews and Statistics - IndexBox
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Privia Health's Premium: A Breakout Play (PRVA) - Seeking Alpha
Why Hims & Hers Health (HIMS) Stock Is Trading Up Today - Yahoo Finance
Hims & Hers Scales AI-Driven Personalized Health and Wellness - The Globe and Mail
Hims & Hers rises after JPMorgan ups position - Sherwood News
Hims & Hers Q3 Preview: Growth Faces a Confidence Test - Yahoo Finance
0.90%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):